Thu, Mar 28, 2019 · 16:40
With the excellent accomplishment of Pharmacovigilance Series of Conferences in the UK, the USA in back to back a long time in the course of the most recent quite a while which met with extraordinary accomplishment in Business Conferencing. It's happy to report thirteenth Global Pharmacovigilance and Drug Safety Summit amid March 28-29, 2019 Osaka, Japan with the topic ‘’Promulgating the prevention of adverse drug reaction". This is a 2-day Mega Event offering Exhibition, at the scene to grandstand the new and rising advancements with Keynote introduction, Oral, YRF (Student Presentation), blurb, e-publication Presentations. We are happy to educate you that the Speaker/Delegate/Exhibitor openings are accessible at the meeting. kindly visit the website of the conference to find out about the scientific sessions and abstract submission, If needs to go to as Delegate, sympathetically enroll to the gathering. For any questions, mail us. Our Confirmed Speakers: Keynote:(Day 1) Dr.Jacob Joseph, Harward Medical School, USA Dr.Ujwala Salvi, Nucleon Therapeutics, India Dr.Omer, Sanofi, Canada Dr.Ashok, Clinfomatrix, USA Other Speakers Mr.Chi Chen, E&Y, China Dr.Meenal Patwardhan, Abbvie, USA Mr.Rajiv Joshi, E&Y, India Keynote (Day 2) Dr.Essam, Celyad, Belgium Dr.Carole, Sun Pharma, Japan Mr.Robert, Accenture, Spain Session Speakers: Mr.Ravish Kumar, Salzman Group, Australia Dr.Abdeen, Ministry of health, UK. Dr.Ripal Gharia, Cliantha research, India Mr.Mohammed Gayoor khan,NFPS,Malaysia Participating Companies: • Abbvie,USA • E&Y, China • Salmanz Group, Australia • Nucleon Therapetics, India • Saudi Patient safety Center, Saudi • AlphaBeta Pharma, UK • King Abdullah Medical City (KAMC) • Takeda, USA Please let me know your confirmation at the earliest convenience. Best Regards Zoey A Williams| Program Coordinator Global Pharmacovigilance 2019 Ph: 4896666555 Ext:6028 Email: